185 related articles for article (PubMed ID: 10838015)
1. Binding of [3H]MSX-2 (3-(3-hydroxypropyl)-7-methyl-8-(m-methoxystyryl)-1-propargylxanthine) to rat striatal membranes--a new, selective antagonist radioligand for A(2A) adenosine receptors.
Müller CE; Maurinsh J; Sauer R
Eur J Pharm Sci; 2000; 10(4):259-65. PubMed ID: 10838015
[TBL] [Abstract][Full Text] [Related]
2. Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes.
Zocchi C; Ongini E; Ferrara S; Baraldi PG; Dionisotti S
Br J Pharmacol; 1996 Apr; 117(7):1381-6. PubMed ID: 8730729
[TBL] [Abstract][Full Text] [Related]
3. Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors.
Cunha RA; Johansson B; Constantino MD; Sebastião AM; Fredholm BB
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):261-71. PubMed ID: 8692280
[TBL] [Abstract][Full Text] [Related]
4. Binding of [3H]KF17837S, a selective adenosine A2 receptor antagonist, to rat brain membranes.
Nonaka H; Mori A; Ichimura M; Shindou T; Yanagawa K; Shimada J; Kase H
Mol Pharmacol; 1994 Nov; 46(5):817-22. PubMed ID: 7969067
[TBL] [Abstract][Full Text] [Related]
5. Water-soluble phosphate prodrugs of 1-propargyl-8-styrylxanthine derivatives, A(2A)-selective adenosine receptor antagonists.
Sauer R; Maurinsh J; Reith U; Fülle F; Klotz KN; Müller CE
J Med Chem; 2000 Feb; 43(3):440-8. PubMed ID: 10669571
[TBL] [Abstract][Full Text] [Related]
6. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
Dionisotti S; Ongini E; Zocchi C; Kull B; Arslan G; Fredholm BB
Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373
[TBL] [Abstract][Full Text] [Related]
7. [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
Jarvis MF; Schulz R; Hutchison AJ; Do UH; Sills MA; Williams M
J Pharmacol Exp Ther; 1989 Dec; 251(3):888-93. PubMed ID: 2600819
[TBL] [Abstract][Full Text] [Related]
8. Competition of adenine nucleotides for a 1,3-[3H]-dipropyl-8-cyclopentylxanthine binding site in rat vas deferens.
Smith AD; Cheek DJ; Buxton IL; Westfall DP
Clin Exp Pharmacol Physiol; 1997 Jul; 24(7):492-7. PubMed ID: 9248666
[TBL] [Abstract][Full Text] [Related]
9. The binding of 1,3-[3H]-dipropyl-8-cyclopentylxanthine to adenosine A1 receptors in rat smooth muscle preparations.
Peachey JA; Hourani SM; Kitchen I
Br J Pharmacol; 1994 Dec; 113(4):1249-56. PubMed ID: 7889280
[TBL] [Abstract][Full Text] [Related]
10. Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists.
Maemoto T; Finlayson K; Olverman HJ; Akahane A; Horton RW; Butcher SP
Br J Pharmacol; 1997 Nov; 122(6):1202-8. PubMed ID: 9401787
[TBL] [Abstract][Full Text] [Related]
11. Differential development of adenosine A1 and A2b receptors in the rat duodenum.
Peachey JA; Hourani SM; Kitchen I
Br J Pharmacol; 1996 Nov; 119(5):949-58. PubMed ID: 8922745
[TBL] [Abstract][Full Text] [Related]
12. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
Alexander SP; Curtis AR; Kendall DA; Hill SJ
Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308
[TBL] [Abstract][Full Text] [Related]
13. Autoradiographic comparison of in vitro binding characteristics of various tritiated adenosine A2A receptor ligands in rat, mouse and pig brain and first ex vivo results.
Sihver W; Schulze A; Wutz W; Stüsgen S; Olsson RA; Bier D; Holschbach MH
Eur J Pharmacol; 2009 Aug; 616(1-3):107-14. PubMed ID: 19545560
[TBL] [Abstract][Full Text] [Related]
14. Adenosine modulation of D-[3H]aspartate release in cultured retina cells exposed to oxidative stress.
Agostinho P; Caseiro P; Rego AC; Duarte EP; Cunha RA; Oliveira CR
Neurochem Int; 2000 Mar; 36(3):255-65. PubMed ID: 10676861
[TBL] [Abstract][Full Text] [Related]
15. Binding of the novel nonxanthine A2A adenosine receptor antagonist [3H]SCH58261 to coronary artery membranes.
Belardinelli L; Shryock JC; Ruble J; Monopoli A; Dionisotti S; Ongini E; Dennis DM; Baker SP
Circ Res; 1996 Dec; 79(6):1153-60. PubMed ID: 8943953
[TBL] [Abstract][Full Text] [Related]
16. G protein coupling of CGS 21680 binding sites in the rat hippocampus and cortex is different from that of adenosine A1 and striatal A2A receptors.
Cunha RA; Constantino MD; Ribeiro JA
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):295-302. PubMed ID: 10344528
[TBL] [Abstract][Full Text] [Related]
17. Further characterization of [3H]-CGS 21680 binding sites in the rat striatum and cortex.
Kirk IP; Richardson PJ
Br J Pharmacol; 1995 Jan; 114(2):537-43. PubMed ID: 7881753
[TBL] [Abstract][Full Text] [Related]
18. Solubilisation and immunoprecipitation of rat striatal adenosine A(2A) receptors.
Harvey V; Jones J; Misra A; Knight AR; Quirk K
Eur J Pharmacol; 2001 Nov; 431(2):171-7. PubMed ID: 11728423
[TBL] [Abstract][Full Text] [Related]
19. 8-(Sulfostyryl)xanthines: water-soluble A2A-selective adenosine receptor antagonists.
Müller CE; Sandoval-Ramírez J; Schobert U; Geis U; Frobenius W; Klotz KN
Bioorg Med Chem; 1998 Jun; 6(6):707-19. PubMed ID: 9681137
[TBL] [Abstract][Full Text] [Related]
20. KW-3902, a selective high affinity antagonist for adenosine A1 receptors.
Nonaka H; Ichimura M; Takeda M; Kanda T; Shimada J; Suzuki F; Kase H
Br J Pharmacol; 1996 Apr; 117(8):1645-52. PubMed ID: 8732272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
